CORD-19:0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e / 16391-16682 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e","sourcedb":"CORD-19","sourceid":"0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e","text":"Patients with a substitution at position I38 in the viral polymerase acidic protein (PA/I38X) of the baloxavir-resistant virus exhibited sustained alleviation and virus clearance, and baloxavir-resistant viruses were not cross-resistant to favipiravir and oseltamivir (Omoto, et al., 2018) .","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T92","span":{"begin":0,"end":291},"obj":"Sentence"},{"id":"T54627","span":{"begin":0,"end":291},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T92","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T54627","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T92","span":{"begin":0,"end":291},"obj":"Sentence"}],"attributes":[{"subj":"T92","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93d3","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93eceb"}]}]}}